Cascades Completes $207-Million Acquisition of Orchids Paper Products Aassets

Cascades, a leader in the recovery and manufacturing of packaging and tissue products, has completed the previously announced acquisition of Orchids Paper Products asset

As mentioned in the July 1 press release, Cascades made the acquisition for a cash consideration of US$207 million. The assets include the Barnwell, SC, and Pryor, OK, operations, as well as certain other assets, including amended supply and other commercial arrangements with Fabrica de Papel San Francisco, based in Mexicali, Mexico, and certain of its affiliates.

Cascades president and CEO, Mario Plourde, comments: "I am very pleased to welcome Pryor and Barnwell employees to the Cascades family. Without a doubt, this acquisition will accelerate the modernization of Cascades' U.S. tissue platform while strengthening the geographic and operational positioning of the Company's retail tissue segment. This transaction creates value for both our clients and for our shareholders with an expected annual EBITDA contribution of approximately US$45 million beginning in 2021."

Cascades Tissue Group president and COO Jean-David Tardif notes: "Today's announcement highlights our commitment to increase our ability to serve our customers and position Cascades, in the tissue paper segment, with a view to long-term growth. Thanks to our strong order book, we can quickly take advantage of maximizing the utilization rate of the acquired facilities."

Over the past five years, more than US$240 million has been invested in the plants' modern production and converting equipment and in establishing a strategic partnership with Fabrica. Orchids Paper's integrated plants have an estimated parent roll capacity of up to 114,000 tpy and up to an estimated 114,500 tpy of converting capacity. The agreement with Fabrica provides access for up to an additional 20,000 tons of converted products for the Western US market. In recent weeks, certain aspects of this agreement have been renegotiated to the satisfaction of both parties.

CIBC Capital Markets is acting as exclusive financial advisor, and K&L Gates as legal counsel, to Cascades in the transaction.

Back to Tissue360 Newsletter